Castleman disease
Open Access
- 1 January 2012
- journal article
- Published by Springer Nature in The Korean Journal of Hematology
- Vol. 47 (3) , 163-177
Abstract
Saeed-Abdul-Rahman I, et al. Korean J Hematol. 2012 Sep;47(3):163-177. http://dx.doi.org/10.5045/kjh.2012.47.3.163Keywords
This publication has 131 references indexed in Scilit:
- Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disordersJournal of Clinical Pathology, 2007
- Cutaneous castleman's disease responds to anti–interleukin-6 treatmentMolecular Cancer Therapeutics, 2007
- ThalidomideThe Lancet, 2004
- Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomideAmerican Journal of Hematology, 2003
- Successful Treatment of Human Immunodeficiency Virus-Related Castleman's Disease with Interferon-Clinical Infectious Diseases, 2000
- Retinoic acid for treatment of multicentric Castleman's diseaseThe Lancet, 1999
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.Journal of Clinical Investigation, 1990
- Hypervascular Follicular Hyperplasia and Kaposi's Sarcoma in Patients at Risk for AIDSNew England Journal of Medicine, 1984